Featured Research

from universities, journals, and other organizations

Young adults want to recover from addiction but need help to make it happen, study suggests

Date:
September 30, 2011
Source:
Hazelden
Summary:
A new study suggests that strong motivation to change may exist from the get-go among young adults with severe addiction problems entering residential treatment, but the know-how and confidence to change come through the treatment experience,.

Young adults undergoing addiction treatment arrive ready and willing to make the personal changes that bring about recovery, but it's the help and guidance received during treatment that build and sustain those changes, according to a longitudinal study published electronically and in press within the journal Drug and Alcohol Dependence. The study was conducted collaboratively by the Center for Addiction Medicine at Massachusetts General Hospital and Harvard Medical School and the Butler Center for Research at Hazelden.

"This study suggests that strong motivation to change may exist from the get-go among young adults with severe addiction problems entering residential treatment, but the know-how and confidence to change come through the treatment experience," explains John F. Kelly, Ph.D., of the Center for Addiction Medicine who authored the study with Center colleagues Karen Urbanoski, Ph.D., and Bettina Hoeppner, Ph.D., and Valerie Slaymaker, Ph.D., of the Butler Center for Research at Hazelden.

Analysis focused on 303 young adults, age 18-24, attending multidisciplinary, Twelve Step-based residential treatment for alcohol or other drug addiction. The study measured the subjects' levels of change during treatment in key areas, including motivation, psychological distress, coping skills and commitment to participation in mutual support groups such as Alcoholics Anonymous or Narcotics Anonymous. Self-efficacy, or a young person's confidence to stay clean and sober, was also assessed. Assessments were made at treatment intake, mid-treatment, at discharge and three months post-discharge.

When entering treatment, study participants reported high levels of motivation to remain abstinent but lower levels of coping skills, self-efficacy and commitment to mutual support groups. During-treatment increases in these measures predicted abstinence from alcohol or other drug use at three months post-treatment. Self-efficacy or increased confidence in ability to sustain recovery was the strongest predictor of abstinence.

Slaymaker of Hazelden adds, "The young people in our study were quite motivated to do well in treatment but lacked the confidence, coping skills, and commitment to AA that are critical to longer-term success. Treatment appears to work by increasing their confidence and ability to make and sustain healthy, recovery-related efforts."

The findings suggest residential treatment provides the boost that the young people need. By reducing their psychological distress, developing their recovery-focused coping skills, increasing their commitment to AA and other groups, and by enhancing their overall confidence to stay clean and sober, young people make meaningful changes in treatment that position them for improved outcomes. Because self-efficacy was a strong predictor of abstinence, it may serve as a useful clinical summary indicator to monitor change and relapse potential among young adults in treatment.

The study, titled "Ready, Willing, and (Not) Able to Change: Young Adults' Response to Residential Treatment," is published in Drug and Alcohol Dependence.


Story Source:

The above story is based on materials provided by Hazelden. Note: Materials may be edited for content and length.


Journal Reference:

  1. J.F. Kelly, K.A. Urbanoski, B.B. Hoeppner, V. Slaymaker. “Ready, willing, and (not) able” to change: Young adults’ response to residential treatment. Drug and Alcohol Dependence, 2011; DOI: 10.1016/j.drugalcdep.2011.09.003

Cite This Page:

Hazelden. "Young adults want to recover from addiction but need help to make it happen, study suggests." ScienceDaily. ScienceDaily, 30 September 2011. <www.sciencedaily.com/releases/2011/09/110930123048.htm>.
Hazelden. (2011, September 30). Young adults want to recover from addiction but need help to make it happen, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/09/110930123048.htm
Hazelden. "Young adults want to recover from addiction but need help to make it happen, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/09/110930123048.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins